ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Schott Pharma AG & CO KGaA

Schott Pharma AG & CO KGaA (1SXP)

16,94
0,34
(2,05%)
Geschlossen 23 Juni 10:00PM

Schott Pharma AG & CO KGaA (1SXP) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
16,94
( 2,05% )
Gebot
16,80
Fragen
17,06
Volumen
5.057
16,60 Tagesbereich 17,06
12,54 52-Wochen-Bereich 29,35
Marktkapitalisierung
Handelsende
16,60
Handelsbeginn
16,60
Letzte Trade
25
@
16.82
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
73.596 €
Ausgegebene Aktien
150.614.616
Dividendenrendite (LTM)
0,18 (1,09%)
Kurs-Gewinn-Verhältnis
17,61
Gewinn pro Aktie (EPS)
0,95
Erlöse (LTM)
991,22M
Nettogewinn (LTM)
142,82M

Über Schott Pharma AG & CO KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ B... SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Mainz, Germany
Gegründet
1884
Schott Pharma AG & CO KGaA is listed in the sector of the Tradegate (DE) with ticker 1SXP. The last closing price for Schott Pharma AG & CO KGaA was 16,60 €. Over the last year, Schott Pharma AG & CO KGaA shares have traded in a share price range of 12,54 € to 29,35 €.

Schott Pharma AG & CO KGaA currently has 150.614.616 shares in issue. The market capitalisation of Schott Pharma AG & CO KGaA is 2,55 € billion. Schott Pharma AG & CO KGaA has a price to earnings ratio (PE ratio) of 17.61.

1SXP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1-5.5741360089217.9418.05999916.059999588516.95545383DE
4-0.1-0.58685446009417.0418.2216.0599991132717.40336651DE
123.6627.560240963913.2818.2213.161239216.03683138DE
26213.386880856814.9418.2212.541847415.20517438DE
52-10.41-38.062157221227.3529.3512.541381416.28249675DE
156-13.06-43.53333333333043.212.54924122.49831449DE
260-13.06-43.53333333333043.212.54924122.49831449DE

1SXP - Frequently Asked Questions (FAQ)

What is the current Schott Pharma AG & CO KGaA share price?
The current share price of Schott Pharma AG & CO KGaA is 16,94 €
How many Schott Pharma AG & CO KGaA shares are in issue?
Schott Pharma AG & CO KGaA has 150.614.616 shares in issue
What is the market cap of Schott Pharma AG & CO KGaA?
The market capitalisation of Schott Pharma AG & CO KGaA is EUR 2,55B
What is the 1 year trading range for Schott Pharma AG & CO KGaA share price?
Schott Pharma AG & CO KGaA has traded in the range of 12,54 € to 29,35 € during the past year
What is the PE ratio of Schott Pharma AG & CO KGaA?
The price to earnings ratio of Schott Pharma AG & CO KGaA is 17,61
What is the cash to sales ratio of Schott Pharma AG & CO KGaA?
The cash to sales ratio of Schott Pharma AG & CO KGaA is 2,54
What is the registered address of Schott Pharma AG & CO KGaA?
The registered address for Schott Pharma AG & CO KGaA is Hattenbergstrasse 10, Mainz, Rhineland-Palatinate, 55122
What is the Schott Pharma AG & CO KGaA website address?
The website address for Schott Pharma AG & CO KGaA is www.schott-pharma.com

1SXP Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen